ANNIE FLANAGAN

Annie Flanagan is an American journalist who has worked in various capacities throughout her career. She has covered a wide range of topics and events, from HIV treatments to local news stories. Flanagan is known for her engaging writing style and ability to connect with readers on important issues. In addition to her journalistic work, she is also involved in community activities and charitable events in Buffalo, New York.

Biography:  https://buffalonews.com/entertainment/television/station-bios-reveal-interesting-tidbits-about-local-tv-personalities/article_8deefcd0-848f-588c-b081-3409962a9584.html

95%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

  • In the biography of morning anchor Melissa Holmes, it is mentioned that she cannot cook despite stating her husband, Jay Skurski, helps with trying new restaurants.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Revolutionizing HIV Treatment: The Promise of Long-Acting Drugs

Revolutionizing HIV Treatment: The Promise of Long-Acting Drugs

Broke On: Monday, 11 March 2024 Scientists are developing long-acting HIV drugs, including once-weekly pills and semiannual shots, which could ease stigma and improve adherence to treatment plans. Companies like Gsk Plc, Merck & Co., Unitaid, and Viiv Healthcare Ltd. aim to make HIV management easier with these innovations.